Virios Therapeutics CEO Greg Duncan's 2021 pay falls 69% to $1.1M
Virios Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 26, 2022
Virios Therapeutics reported fiscal year 2021 executive compensation information on April 26, 2022.
In 2021, four executives at Virios Therapeutics received on average a compensation package of $657K, a 59% decrease compared to previous year.
Average pay of disclosed executives at Virios Therapeutics
Greg Duncan, Chief Executive Officer, received $1.1M in total, which decreased by 69% compared to 2020. 47% of Duncan's compensation, or $513K, was in salary. Duncan also received $256K in non-equity incentive plan, $301K in option awards, as well as $30K in other compensation.
R. Michael Gendreau, Chief Medical Officer, received a compensation package of $688K, which increased by 2194% compared to previous year. 47% of the compensation package, or $325K, was in salary.
Ralph Grosswald, Vice President of Operations, earned $425K in 2021, a 8% decrease compared to previous year.
Angela Walsh, Senior Vice President of Finance, received $414K in 2021, which decreases by 14% compared to 2020.
Related executives
You may also like
Source: SEC filing on April 26, 2022.